These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 19934396
1. Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis. Bliziotis IA, Plessa E, Peppas G, Falagas ME. Ann Pharmacother; 2010 Jan; 44(1):97-106. PubMed ID: 19934396 [Abstract] [Full Text] [Related]
2. Daptomycin: rationale and role in the management of skin and soft tissue infections. Seaton RA. J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721 [Abstract] [Full Text] [Related]
3. Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections. Logman JF, Stephens J, Heeg B, Haider S, Cappelleri J, Nathwani D, Tice A, van Hout BA. Curr Med Res Opin; 2010 Jul; 26(7):1565-78. PubMed ID: 20429820 [Abstract] [Full Text] [Related]
6. Management of cSSTIs: the role of daptomycin. Garau J. Curr Med Res Opin; 2006 Nov; 22(11):2079-87. PubMed ID: 17076967 [Abstract] [Full Text] [Related]
8. [Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections]. Mathiesen L, Midtvedt T, Solberg CO. Tidsskr Nor Laegeforen; 2006 Sep 21; 126(18):2383-4. PubMed ID: 16998552 [Abstract] [Full Text] [Related]
9. Effectiveness and safety of daptomycin in complicated skin and soft-tissue infections and bacteraemia in clinical practice: results of a large non-interventional study. Gonzalez-Ruiz A, Beiras-Fernandez A, Lehmkuhl H, Dohmen PM, Loeffler J, Chaves RL. Int J Antimicrob Agents; 2013 Apr 21; 41(4):372-8. PubMed ID: 23499225 [Abstract] [Full Text] [Related]
10. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin. Owens RC, Lamp KC, Friedrich LV, Russo R. Am J Med; 2007 Oct 21; 120(10 Suppl 1):S6-12. PubMed ID: 17904950 [Abstract] [Full Text] [Related]
11. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria. Stryjewski ME, O'Riordan WD, Lau WK, Pien FD, Dunbar LM, Vallee M, Fowler VG, Chu VH, Spencer E, Barriere SL, Kitt MM, Cabell CH, Corey GR, FAST Investigator Group. Clin Infect Dis; 2005 Jun 01; 40(11):1601-7. PubMed ID: 15889357 [Abstract] [Full Text] [Related]
17. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials. Kyriakidou KG, Rafailidis P, Matthaiou DK, Athanasiou S, Falagas ME. Clin Ther; 2008 Oct 01; 30(10):1859-68. PubMed ID: 19014841 [Abstract] [Full Text] [Related]
18. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI, Daptomycin 98-01 and 99-01 Investigators. Clin Infect Dis; 2004 Jun 15; 38(12):1673-81. PubMed ID: 15227611 [Abstract] [Full Text] [Related]
19. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. Lipsky BA, Stoutenburgh U. J Antimicrob Chemother; 2005 Feb 15; 55(2):240-5. PubMed ID: 15659542 [Abstract] [Full Text] [Related]